Ladenburg Thalmann Financial Services’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $57K | Buy |
1,063
+269
| +34% | +$14.4K | ﹤0.01% | 3444 |
|
|
2019
Q3 | $32K | Buy |
794
+116
| +17% | +$4.68K | ﹤0.01% | 3742 |
|
|
2019
Q2 | $29K | Hold |
678
| – | – | ﹤0.01% | 3838 |
|
|
2019
Q1 | $32K | Buy |
678
+100
| +17% | +$4.72K | ﹤0.01% | 3716 |
|
|
2018
Q4 | $26K | Buy |
578
+443
| +328% | +$19.9K | ﹤0.01% | 3719 |
|
|
2018
Q3 | $8K | Sell |
135
-2
| -1% | -$119 | ﹤0.01% | 4415 |
|
|
2018
Q2 | $6K | Hold |
137
| – | – | ﹤0.01% | 4544 |
|
|
2018
Q1 | $6K | Hold |
137
| – | – | ﹤0.01% | 4544 |
|
|
2017
Q4 | $6K | Buy |
137
+42
| +44% | +$1.84K | ﹤0.01% | 4473 |
|
|
2017
Q3 | $4K | Hold |
95
| – | – | ﹤0.01% | 4517 |
|
|
2017
Q2 | $3K | Hold |
95
| – | – | ﹤0.01% | 4520 |
|
|
2017
Q1 | $2K | Sell |
95
-22
| -19% | -$463 | ﹤0.01% | 4618 |
|
|
2016
Q4 | $4K | Buy |
117
+4
| +4% | +$137 | ﹤0.01% | 4354 |
|
|
2016
Q3 | $4K | Buy |
113
+100
| +769% | +$3.54K | ﹤0.01% | 4304 |
|
|
2016
Q2 | $0 | Hold |
13
| – | – | ﹤0.01% | 4887 |
|
|
2016
Q1 | $0 | Sell |
13
-15
| -54% | – | ﹤0.01% | 4862 |
|
|
2015
Q4 | $1K | Buy |
+28
| New | +$1K | ﹤0.01% | 4579 |
|